Cargando…
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), which belong to the same Betacoronavirus genus, induces severe acute respiratory disease that is a threat to human health. Since the outbreak of infection by...
Autores principales: | He, Jun, Hu, Lijun, Huang, Xiaojun, Wang, Chenran, Zhang, Zhimin, Wang, Ying, Zhang, Dongmei, Ye, Wencai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286838/ https://www.ncbi.nlm.nih.gov/pubmed/32534187 http://dx.doi.org/10.1016/j.ijantimicag.2020.106055 |
Ejemplares similares
-
Validation and Invalidation of SARS-CoV-2 Papain-like
Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2022) -
QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
por: Ishola, Ahmed Adebayo, et al.
Publicado: (2021) -
Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease
por: Bosken, Yuliana K., et al.
Publicado: (2020) -
Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2
por: Chen, Junjie, et al.
Publicado: (2022) -
Synergistic Inhibitor Binding to the Papain‐Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications
por: Lee, Hyun, et al.
Publicado: (2013)